Disproportionality analysis of adverse events associated with asfotase alfa: a post-marketing study using the FDA Adverse Event Reporting System
Most AEs align with known data, but newly identified ear/labyrinth disorders and infections require further investigation to enhance AA's safety profile.
Authors
- Wen Wang (ORCID: https://orcid.org/0000-0003-3215-3020)
- Sun Haixia
- Zhe Wang (ORCID: https://orcid.org/0000-0001-7666-0396)
- Hao Lv (ORCID: https://orcid.org/0000-0001-5097-395X)
- Chen Qianxiu
- Fu Zongchao
- Jing Han (ORCID: https://orcid.org/0000-0003-0048-2241)
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1080/14740338.2024.2433566
- Primary Topic
- Alkaline Phosphatase Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Taishan Scholar Project of Shandong Province